Could stem cell secretions help seniors regain muscle strength?
NCT ID NCT06600581
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This phase 2 trial tests whether a substance called IMM01-STEM, made from secretions of stem cells, can safely improve muscle performance in seniors aged 60-80 who have both obesity and muscle weakness (sarcopenic obesity). Participants receive injections twice a week for a period, and researchers monitor side effects and changes in walking speed and grip strength. The study involves 55 people and compares the treatment to a placebo.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
IMM01-STEM (a mixture of molecules secreted by stem cells)
What this could lead to
If it works, this could lead to a new treatment that helps older adults with obesity and muscle weakness regain strength and mobility.
What could go wrong
This is a small, early-phase trial with only 55 participants. The treatment may not work better than placebo, and side effects are still being studied.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SARCOPENIC OBESITY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Johnson Country Clinical Trials (JCCT)
Lenexa, Kansas, 66219, United States
-
National Institute of Clinical Research (NICR)
Garden Grove, California, 92844, United States
-
National Institute of Clinical Research (NICR)
Pomona, California, 91768, United States
-
Tekton Research
Wichita, Kansas, 67218, United States